Yingbo Lin

1.2k total citations
49 papers, 978 citations indexed

About

Yingbo Lin is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yingbo Lin has authored 49 papers receiving a total of 978 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 14 papers in Cancer Research and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yingbo Lin's work include Animal Virus Infections Studies (6 papers), Sarcoma Diagnosis and Treatment (6 papers) and Ubiquitin and proteasome pathways (5 papers). Yingbo Lin is often cited by papers focused on Animal Virus Infections Studies (6 papers), Sarcoma Diagnosis and Treatment (6 papers) and Ubiquitin and proteasome pathways (5 papers). Yingbo Lin collaborates with scholars based in Sweden, China and United States. Yingbo Lin's co-authors include Olle Larsson, Bita Sehat, Eric Trocmé, Jens Lagergren, Ali Asghar Tofigh, Ulrika Liljedahl, Felix Haglund, Jianping Liu, Helena Jernberg‐Wiklund and Zhixian Mo and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Circulation Research.

In The Last Decade

Yingbo Lin

48 papers receiving 966 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yingbo Lin Sweden 18 564 199 186 175 102 49 978
Wen Cao China 19 758 1.3× 330 1.7× 126 0.7× 196 1.1× 308 3.0× 30 1.5k
Francesca Trapani Italy 13 744 1.3× 321 1.6× 64 0.3× 177 1.0× 93 0.9× 21 1.2k
Abdel A. Alli United States 25 971 1.7× 154 0.8× 93 0.5× 196 1.1× 100 1.0× 81 1.5k
István Likó Hungary 21 669 1.2× 483 2.4× 348 1.9× 133 0.8× 95 0.9× 71 1.4k
Benoît Hennuy Belgium 21 484 0.9× 177 0.9× 120 0.6× 139 0.8× 171 1.7× 33 1.1k
Laura Iris Cosen-Binker Canada 17 372 0.7× 123 0.6× 56 0.3× 148 0.8× 125 1.2× 27 948
Yuxin Xu China 25 1.1k 2.0× 282 1.4× 109 0.6× 251 1.4× 235 2.3× 94 1.9k
Ning Dai United States 12 847 1.5× 388 1.9× 57 0.3× 92 0.5× 222 2.2× 15 1.2k
Tsuyoshi Kawabata Japan 16 779 1.4× 168 0.8× 58 0.3× 132 0.8× 164 1.6× 28 1.6k
Gang Han China 19 685 1.2× 218 1.1× 32 0.2× 115 0.7× 93 0.9× 57 1.0k

Countries citing papers authored by Yingbo Lin

Since Specialization
Citations

This map shows the geographic impact of Yingbo Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yingbo Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yingbo Lin more than expected).

Fields of papers citing papers by Yingbo Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yingbo Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yingbo Lin. The network helps show where Yingbo Lin may publish in the future.

Co-authorship network of co-authors of Yingbo Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yingbo Lin. A scholar is included among the top collaborators of Yingbo Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yingbo Lin. Yingbo Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Öfverholm, Ingegerd, Johan Wejde, Valtteri Wirta, et al.. (2024). Comprehensive Genomic Profiling Alters Clinical Diagnoses in a Significant Fraction of Tumors Suspicious of Sarcoma. Clinical Cancer Research. 30(12). 2647–2658. 4 indexed citations
2.
Öfverholm, Ingegerd, Yingbo Lin, Robert Bränström, et al.. (2024). Prospective Screening of Cancer Syndromes in Patients with Mesenchymal Tumors. Cancers. 16(22). 3816–3816.
3.
Yang, Ying, Lijun Li, Mei‐Ling Cheng, et al.. (2023). RACK1 promotes porcine reproductive and respiratory syndrome virus infection in Marc-145 cells through ERK1/2 activation. Virology. 588. 109886–109886. 3 indexed citations
4.
Öfverholm, Ingegerd, et al.. (2023). Sarcoma care in the era of precision medicine. Journal of Internal Medicine. 294(6). 690–707. 13 indexed citations
6.
Lin, Yingbo, Chan Li, Jīng Li, et al.. (2022). Ginsenoside Rg1 mitigates morphine dependence via regulation of gut microbiota, tryptophan metabolism, and serotonergic system function. Biomedicine & Pharmacotherapy. 150. 112935–112935. 24 indexed citations
7.
Li, Dan, Ningning Wang, Jiayu Chen, et al.. (2021). High Expression of LINC01268 is Positively Associated with Hepatocellular Carcinoma Progression via Regulating MAP3K7. OncoTargets and Therapy. Volume 14. 1753–1769. 2 indexed citations
8.
Zhang, Yifan, Yi Chen, Yang Chen, et al.. (2021). TERT promoter mutation is an objective clinical marker for disease progression in chondrosarcoma. Modern Pathology. 34(11). 2020–2027. 25 indexed citations
9.
Zhang, Jing, Jing Li, Subee Tan, et al.. (2020). Inhibition of miR-1193 leads to synthetic lethality in glioblastoma multiforme cells deficient of DNA-PKcs. Cell Death and Disease. 11(7). 602–602. 17 indexed citations
10.
Chen, Yang, Yifan Zhang, Yi Chen, et al.. (2020). Nuclear IGF1R interact with PCNA to preserve DNA replication after DNA-damage in a variety of human cancers. PLoS ONE. 15(7). e0236291–e0236291. 12 indexed citations
11.
Wang, Xiaochun, Xiaoying Yang, Rui Lan, et al.. (2020). Porcine RACK1 negatively regulates the infection of classical swine fever virus and the NF-κB activation in PK-15 cells. Veterinary Microbiology. 246. 108711–108711. 10 indexed citations
12.
Xie, Bu‐Shan, et al.. (2019). High-throughput screening identified mitoxantrone to induce death of hepatocellular carcinoma cells with autophagy involvement. Biochemical and Biophysical Research Communications. 521(1). 232–237. 17 indexed citations
13.
Lin, Yingbo, Asle C. Hesla, Mehran Ghaderi, et al.. (2018). Telomerase promoter mutations and copy number alterations in solitary fibrous tumours. Journal of Clinical Pathology. 71(9). 832–839. 15 indexed citations
14.
Lin, Yingbo, Yi Chen, Asle C. Hesla, et al.. (2018). hTERT promoter mutations in chondrosarcomas associate with progression and disease-related mortality. Modern Pathology. 31(12). 1834–1841. 12 indexed citations
15.
Lin, Yingbo, Hongyu Liu, Felix Haglund, et al.. (2017). SUMO‐modified insulin‐like growth factor 1 receptor (IGF‐1R) increases cell cycle progression and cell proliferation. Journal of Cellular Physiology. 232(10). 2722–2730. 36 indexed citations
16.
Zhao, Zhiwei, Yingbo Lin, Yali Miao, et al.. (2017). Epithelial-mesenchymal transition in cancer: Role of the IL-8/IL-8R axis. Oncology Letters. 13(6). 4577–4584. 31 indexed citations
17.
Fang, Miao, Daoqi Zhu, Chaohua Luo, et al.. (2016). An In Vivo Assessment: Cardiotoxicity Induced by Three Kinds of Addictive Drugs (Methamphetamine, Ketamine, and Methadone) in Zebrafish Embryos. 2016(3). 1–4. 4 indexed citations
18.
Lin, Yingbo, et al.. (2014). Nuclear translocation of IGF-1R via p150Glued and an importin-β/RanBP2-dependent pathway in cancer cells. Oncogene. 34(17). 2227–2238. 52 indexed citations
19.
Ibarra, Cristián, José M. Vicencio, Manuel Estrada, et al.. (2012). Local Control of Nuclear Calcium Signaling in Cardiac Myocytes by Perinuclear Microdomains of Sarcolemmal Insulin-Like Growth Factor 1 Receptors. Circulation Research. 112(2). 236–245. 67 indexed citations
20.
Aleem, Eiman, et al.. (2011). Multiple antitumor effects of picropodophyllin in colon carcinoma cell lines: Clinical implications. International Journal of Oncology. 40(4). 1251–1258. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026